C4X Discovery

C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular structures with high accuracy, C4X Discovery is focused on optimising the design and development of medicines and partnering with the pharmaceutical sector to generate better, safer products. C4X Discovery is able to determine the bioactive 3D structures of a variety of biologically important molecules, including drugs, naturally occurring ligands and enzyme co-factors, and does this independently of traditional methods such as computational modelling and X-ray crystallography. C4X Discovery is applying its unique technology to improve the efficiency of the drug discovery process, both in partnership with the pharmaceutical industry and across its own pipeline of high-value therapeutic targets.
Manchester, GB
19 (est)
C4X Discovery was founded in 2007 and is headquartered in Manchester, GB

C4X Discovery Locations

Manchester, GB

C4X Discovery Metrics

C4X Discovery Summary

Market capitalization

£28.8 M

Closing share price

C4X Discovery's latest market capitalization is £28.8 M.

C4X Discovery Financials

C4X Discovery's revenue was £312 K in FY, 2015 which is 49.6% decrease from the previous period.
FY, 2014FY, 2015


£619 K£312 K

Revenue growth, %


Cost of sales

£23 K£112 K

Gross profit

£596 K£200 K

Gross profit Margin, %


Operating expense total

£1.82 M£4.06 M

C4X Discovery Market Value History

13% of current employees of C4X Discovery are female and 87% are male.

C4X Discovery News

C4X Discovery Company Life

You may also be interested in